Cargando…
Excitatory and inhibitory neuronal signaling in inflammatory and diabetic neuropathic pain
Pain, although unpleasant, is an essential warning mechanism against injury and damage of the organism. An intricate network of specialised sensors and transmission systems contributes to reception, transmission and central sensitization of pain. Here, we briefly introduce some of the main aspects o...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111846/ https://www.ncbi.nlm.nih.gov/pubmed/37069517 http://dx.doi.org/10.1186/s10020-023-00647-0 |
_version_ | 1785027530705600512 |
---|---|
author | Breitinger, Ulrike Breitinger, Hans-Georg |
author_facet | Breitinger, Ulrike Breitinger, Hans-Georg |
author_sort | Breitinger, Ulrike |
collection | PubMed |
description | Pain, although unpleasant, is an essential warning mechanism against injury and damage of the organism. An intricate network of specialised sensors and transmission systems contributes to reception, transmission and central sensitization of pain. Here, we briefly introduce some of the main aspects of pain signal transmission, including nociceptors and nociceptive signals, mechanisms of inflammatory and neuropathic pain, and the situation of diabetes-associated neuropathic pain. The role of glia—astrocytes, microglia, satellite glia cells—and their specific channels, transporters and signaling pathways is described. A focus is on the contribution of inhibitory synaptic signaling to nociception and a possible role of glycine receptors in glucose-mediated analgesia and treatment-induced diabetic neuropathy. Inhibitory receptors such as GABA(A)- and glycine receptors are important contributors to nociceptive signaling; their contribution to altered pain sensation in diabetes may be of clinical relevance, and they could be promising therapeutic targets towards the development of novel analgesics. |
format | Online Article Text |
id | pubmed-10111846 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-101118462023-04-19 Excitatory and inhibitory neuronal signaling in inflammatory and diabetic neuropathic pain Breitinger, Ulrike Breitinger, Hans-Georg Mol Med Review Pain, although unpleasant, is an essential warning mechanism against injury and damage of the organism. An intricate network of specialised sensors and transmission systems contributes to reception, transmission and central sensitization of pain. Here, we briefly introduce some of the main aspects of pain signal transmission, including nociceptors and nociceptive signals, mechanisms of inflammatory and neuropathic pain, and the situation of diabetes-associated neuropathic pain. The role of glia—astrocytes, microglia, satellite glia cells—and their specific channels, transporters and signaling pathways is described. A focus is on the contribution of inhibitory synaptic signaling to nociception and a possible role of glycine receptors in glucose-mediated analgesia and treatment-induced diabetic neuropathy. Inhibitory receptors such as GABA(A)- and glycine receptors are important contributors to nociceptive signaling; their contribution to altered pain sensation in diabetes may be of clinical relevance, and they could be promising therapeutic targets towards the development of novel analgesics. BioMed Central 2023-04-17 /pmc/articles/PMC10111846/ /pubmed/37069517 http://dx.doi.org/10.1186/s10020-023-00647-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Breitinger, Ulrike Breitinger, Hans-Georg Excitatory and inhibitory neuronal signaling in inflammatory and diabetic neuropathic pain |
title | Excitatory and inhibitory neuronal signaling in inflammatory and diabetic neuropathic pain |
title_full | Excitatory and inhibitory neuronal signaling in inflammatory and diabetic neuropathic pain |
title_fullStr | Excitatory and inhibitory neuronal signaling in inflammatory and diabetic neuropathic pain |
title_full_unstemmed | Excitatory and inhibitory neuronal signaling in inflammatory and diabetic neuropathic pain |
title_short | Excitatory and inhibitory neuronal signaling in inflammatory and diabetic neuropathic pain |
title_sort | excitatory and inhibitory neuronal signaling in inflammatory and diabetic neuropathic pain |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111846/ https://www.ncbi.nlm.nih.gov/pubmed/37069517 http://dx.doi.org/10.1186/s10020-023-00647-0 |
work_keys_str_mv | AT breitingerulrike excitatoryandinhibitoryneuronalsignalingininflammatoryanddiabeticneuropathicpain AT breitingerhansgeorg excitatoryandinhibitoryneuronalsignalingininflammatoryanddiabeticneuropathicpain |